<DOC>
	<DOC>NCT02161692</DOC>
	<brief_summary>The purpose of this study is to determine whether the use of a sequential high dose chemotherapy is more effective than conventional dose (i.e. 4 cycles of cisplatin, etoposide, and bleomycin [PEB]) in patients with metastatic poor prognosis germ cell tumors.</brief_summary>
	<brief_title>Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms, Germ Cell and Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Clinical or Histological diagnosis of germ cell tumors Metastatic disease Poor prognostic category according to the International Germ Cell Collaborative Group (IGCCCG) classification No prior chemotherapy for metastatic disease Unwillingness to accomplish the study procedures Any existing comorbidity that could limit the administration of high dose chemotherapy Any psychiatric disorder that could impact on the study compliance</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>